Pnc Financial Services Group, Inc. Agios Pharmaceuticals, Inc. Transaction History

Pnc Financial Services Group, Inc.

$156 Billion
Q3 2024

A detailed history of Pnc Financial Services Group, Inc. transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 3,555 shares of AGIO stock, worth $197,942. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,555

Previous 3,506 1.4%

Holding current value

$197,942

Previous $151,000 3.97%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$41.19 - $49.72 $2,018 - $2,436	49 Added 1.4%	3,555 $157,000
Q2 2024 Aug 09, 2024	BUY	$27.55 - $48.83 $468 - $830	17 Added 0.49%	3,506 $151,000
Q1 2024 May 10, 2024	BUY	$21.32 - $34.81 $64,493 - $105,300	3,025 Added 651.94%	3,489 $102,000
Q4 2023 Feb 09, 2024	BUY	$19.97 - $24.53 $3,295 - $4,047	165 Added 55.18%	464 $10,000
Q3 2023 Nov 13, 2023	SELL	$24.36 - $28.18 $4,287 - $4,959	-176 Reduced 37.05%	299 $7,000
Q2 2023 Aug 11, 2023	BUY	$21.38 - $29.19 $3,762 - $5,137	176 Added 58.86%	475 $13,000
Q1 2023 May 15, 2023	SELL	$21.74 - $30.93 $108 - $154	-5 Reduced 1.64%	299 $6,000
Q4 2022 Feb 10, 2023	SELL	$24.81 - $31.52 $4,962 - $6,304	-200 Reduced 39.68%	304 $8,000
Q3 2022 Nov 10, 2022	SELL	$19.51 - $34.14 $1,814 - $3,175	-93 Reduced 15.58%	504 $14,000
Q2 2022 Aug 12, 2022	SELL	$17.06 - $31.42 $767 - $1,413	-45 Reduced 7.01%	597 $13,000
Q1 2022 May 12, 2022	BUY	$26.68 - $34.81 $16,034 - $20,920	601 Added 1465.85%	642 $18,000
Q4 2021 Feb 11, 2022	SELL	$29.58 - $49.78 $236 - $398	-8 Reduced 16.33%	41 $1,000
Q2 2021 Aug 06, 2021	SELL	$52.06 - $61.27 $5,830 - $6,862	-112 Reduced 69.57%	49 $2,000
Q1 2021 May 07, 2021	BUY	$44.23 - $57.5 $353 - $460	8 Added 5.23%	161 $8,000
Q4 2020 Feb 12, 2021	SELL	$33.21 - $46.54 $50,113 - $70,228	-1,509 Reduced 90.79%	153 $6,000
Q3 2020 Nov 06, 2020	SELL	$33.87 - $55.93 $338 - $559	-10 Reduced 0.6%	1,662 $58,000
Q2 2020 Aug 07, 2020	BUY	$34.45 - $53.48 $53,121 - $82,466	1,542 Added 1186.15%	1,672 $89,000
Q1 2020 May 08, 2020	SELL	$31.52 - $53.81 $1,639 - $2,798	-52 Reduced 28.57%	130 $4,000
Q4 2019 Feb 07, 2020	SELL	$30.08 - $50.59 $3,158 - $5,311	-105 Reduced 36.59%	182 $8,000
Q3 2019 Nov 08, 2019	SELL	$32.4 - $49.58 $38,685 - $59,198	-1,194 Reduced 80.62%	287 $9,000
Q2 2019 Aug 09, 2019	SELL	$46.17 - $68.1 $4,339 - $6,401	-94 Reduced 5.97%	1,481 $0
Q1 2019 May 10, 2019	BUY	$45.92 - $67.67 $28,791 - $42,429	627 Added 66.14%	1,575 $0
Q4 2018 Feb 08, 2019	BUY	$42.73 - $76.53 $2,136 - $3,826	50 Added 5.57%	948 $43,000
Q3 2018 Nov 09, 2018	BUY	$71.67 - $91.95 $29,098 - $37,331	406 Added 82.52%	898 $0
Q1 2018 May 11, 2018	BUY	$59.83 - $86.53 $23,513 - $34,006	393 Added 396.97%	492 $0
Q4 2017 Feb 09, 2018	BUY	$52.12 - $72.33 $2,814 - $3,905	54 Added 120.0%	99 $0
Q3 2017 Nov 13, 2017	BUY	$54.89 - $67.12 $2,470 - $3,020	45	45 $0

Others Institutions Holding AGIO

# of Institutions

232

Shares Held

58.1M

Call Options Held

403K

Put Options Held

469K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.05B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Account

Pnc Financial Services Group, Inc. Agios Pharmaceuticals, Inc. Transaction History